Delivery Order SPE2DE24DA017-SPE2D625F2SYE
Award Date 9/5/25
Potential Completion Date 9/10/25
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $52,879.14 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for an ACP MAX PRP System with ACDA technology. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) valued at $471 million and running through September 1, 2029. The contract carries no set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $1,817.64 delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for an ACP MAX PRP (Autologous Conditioned Plasma Maximum Platelet-Rich Plasma) System with Autologous Conditioned Plasma technology. This fixed-price contract with economic price adjustment provisions is set to conclude by August 18, 2025, and represents a task order under Arthrex's larger Indefinite...
- Arthrex Inc., a leading global provider of minimally invasive orthopedic medical technologies based in Naples, Florida, has been awarded a delivery order valued at $1,817.64 for an ACP MAX PRP System with ACDA under a Defense Logistics Agency Medical Supply Chain contract. The award, announced on August 29, 2025, is a fixed-price delivery order with economic price adjustment provisions and is set to be completed by September 4, 2025. This delivery order falls under Arthrex's larger Indefinite...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,029.40 on August 27, 2025, for the ACP MAX PRP System with ACDA (autologous conditioned plasma). This fixed-price delivery order with economic price adjustment is scheduled for completion by September 2, 2025, and represents performance under Arthrex's larger indefinite delivery contract with the Defense Logistics Agency's Medical Supply Chain. The order...
- Arthrex Inc. has been awarded a delivery order valued at $3,635.28 by the Defense Logistics Agency's Medical Supply Chain for an ACP MAX PRP System with ACDA functionality. The contract, issued on August 29, 2025, carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 4, 2025. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, a $471...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,817.64 fixed-price delivery order to Arthrex Inc. on June 2, 2025, with a completion date of June 5, 2025. This order falls under Arthrex's existing indefinite delivery contract (IDC SPE2DE24D0020) valued at $471.0 million and running through September 1, 2029. The delivery order is for ACP MAX PRP System components with ACDA integration, which Arthrex will supply to the Naples, Florida location. The award was not set aside...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $2,475 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment capability was awarded on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract represents no set-aside designation,...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,960 delivery order to Arthrex Inc. on August 21, 2025, for the ACP MAX PRP System (OUS/EU). This fixed-price contract with economic price adjustment represents task order activity under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471 million and spanning June 2024 through September 2029. The delivery order is not designated as a set-aside and is scheduled for...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a delivery order valued at $17,661.60 on May 30, 2025, for an ACP MAX PRP (Autologous Conditioned Plasma Maximum Platelet-Rich Plasma) System for overseas and European use. This fixed-price contract with economic price adjustment represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, a $471 million...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a fixed-price delivery order valued at $3,577.20 from the Defense Logistics Agency's Medical Supply Chain on August 1, 2025, with an ultimate completion date of August 6, 2025. The delivery order covers the Arthrex ANGEL PRP Kit for the U.S. market, a specialized medical device used in orthopedic procedures. This award was not set aside for any specific business category, reflecting...